Tag Archives: Venture Philanthropy

RESI on MaRS Panel Announcement: Venture Philanthropy

29 Mar

By James Huang, Research Analyst, LSN

james-wp

RESI endeavors to bring a diverse pool of investors to each of our events for early stage life science companies. Among them are venture philanthropic foundations whose profound expertise within their targeted disease areas makes them great resources for any entrepreneur looking to work within their areas of expertise. Additionally, venture philanthropic investors tend to focus on assets at an earlier stage than typical VCs, with the aim of helping new treatments traverse the infamous “Valley of Death.”

LSN is pleased to announce a panel of five venture philanthropic investors for the upcoming RESI on MaRS this April 10th in Toronto. In this panel, these investors will explain their unique strategies and expertise, and entrepreneurs can learn how to find and work with a venture philanthropy investor in their domain. RESI attendees will have the exclusive opportunity to hear from:

RESI New York City: Venture Philanthropy Panel Announcement

2 Nov

By Christine A. Wu, Senior Research Analyst, LSN

chrsitine

Venture philanthropic foundations have deep expertise that is often overlooked. Each foundation has a specific, genuine mission towards a disease area that provides them enormous capacity to bring forward more than any entrepreneur can realize. Along with funding, venture philanthropic investors can provide patient access for underserved populations, specialize in assessing and tracking “positively impactful” technology in their particular field, and utilize their own relationships with traditional ventures in creative ways, among other initiatives.

New York City is home to a great number of life science foundations. LSN has dedicated the Venture Philanthropy panel to the following five incredible Foundations for the RESI New York City Conference on November 15th. Moderated by John Walter, CEO and President of Alliance for Cancer Gene Therapy, the audience will have an exclusive opportunity to hear from:

  • Alyssa Reimer, Associate Director, Research Partnerships, The Michael J. Fox Foundation for Parkinson’s Research
  • Michael Batten, Director, Strategic Partnerships, Juvenile Diabetes Research Foundation (JDRF) T1D Fund
  • Ken LaMontagne, VP of Research, Therapy Acceleration Program, Leukemia & Lymphoma Society
  • Andres Hurtado-Lorenzo, Director of Translational Research, Crohn’s and Colitis Foundation

Venture philanthropy investors maintain the genuine purpose of moving forward in the field of life science. Non-traditional investors such as these groups are great funding sources with incredible knowledge in their fields, while also taking inspirational strides to achieve their goals.

Foundations are a strong reminder not to lose track of the mission in life science.

Register before it’s too late to hear first-hand from this fantastic panel!

RESI San Diego: Venture Philanthropy Panel Announcement

18 May

By Christine A. Wu, Senior Research Analyst, LSN

chrsitine

Investors in venture philanthropy, such as foundations and specific family offices, have deep expertise that is often overlooked. Many venture philanthropic groups have a specific mission in a disease area that provides them enormous capacity to bring forward more than any entrepreneur can realize. Along with funding, venture philanthropic investors can provide patient access for underserved populations, specialize in assessing and tracking “positively impactful” technology in their particular field, and utilize their own relationships with traditional ventures in creative ways, among other initiatives.

LSN is pleased to announce a panel of five expert venture philanthropic investors for the RESI San Diego Conference on June 19th. The audience will have an exclusive opportunity to hear from:

Venture philanthropy investors maintain the genuine purpose of moving forward in the field of life science. Non-traditional investors such as these groups are great funding sources with incredible knowledge in their fields, while also taking inspirational strides to achieve their goals. Be sure not to lose track of the mission in life science, and not miss the opportunity of hearing how these panelists can help you with your philanthropic mission.

Register by Friday to save $200, be the first to request investor meetings on partnering, and hear from this fantastic panel!

RESI@TMCx Panel Announcement: Venture Philanthropy Investors

10 Mar

By Christine A. Wu, Research Analyst, LSN

chrsitine

Venture philanthropy organizations provide more than just financing. Often times, these investors can provide a network of experts, patients, and resources in their niche space. Here in Next Phase, LSN has previously covered trends in venture philanthropy investment and advice in how to approach venture philanthropy investors.

LSN is pleased to announce a panel of five investors in the venture philanthropy space for RESI@TMCx on April 11th. Moderated by Jit Patel, VP of Research and Business Development of Juvenile Diabetes Research Foundation (JDRF), the panel will be joined by:

Panelists will address their specific investment criteria and unique missions; their investment decision-making process; important trends in the space; and the best approach to reach and heighten their interest.

Interested in this panel? It’s not too late to register for RESI@TMCx Houston and see this panel live. View the full RESI@TMCx agenda here. You can also view a video recap of our RESI San Francisco Venture Philanthropy session.

RESI-Houston-2016_600

Panel Announcement: Venture Philanthropy Investors

19 Nov

By Christine A. Wu, Research Analyst, LSN

chrsitine

Venture philanthropy has been a vital source of capital for early stage life science companies over the years. Philanthropic organizations provide more than just financing; a foundation with a niche indication focus may supply a network of experts, patients, and resources in the field. These organizations have an underlying mission to improve specific patient outcomes, going as far as using their financial returns toward further initiatives and investments to achieve their mission. Due to these organizations’ unique missions, LSN has uncovered a number of investment trends and accumulated advice in how to approach venture philanthropy investors.

LSN is pleased to announce a panel of five expert representatives in the venture philanthropy space for the RESI San Francisco Conference on January 12th. Moderated by Chris de Souza, Director of Broadview Ventures, the panel will be joined by:

Panelists will address their specific investment criteria and unique missions; their particular investment decision-making process; the relevant questions to ask and the best approach to reach and heighten their interest; along with important trends to keep in mind.

If venture philanthropy investment is part of your plan to get your company funded, this panel is a fantastic opportunity to extend your network and expand your understanding of these organizations.

RESI-San-Francisco-2016

%d bloggers like this: